Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

INVO Fertility (IVF) Payables (2016 - 2025)

INVO Fertility has reported Payables over the past 16 years, most recently at $2.5 million for Q3 2025.

  • Quarterly Payables fell 74.9% to $2.5 million in Q3 2025 from the year-ago period, while the trailing twelve-month figure was $2.5 million through Sep 2025, down 74.9% year-over-year, with the annual reading at $4.0 million for FY2024, 21.61% down from the prior year.
  • Payables was $2.5 million for Q3 2025 at INVO Fertility, down from $5.1 million in the prior quarter.
  • Over five years, Payables peaked at $11.3 million in Q1 2025 and troughed at $306252.0 in Q2 2021.
  • The 5-year median for Payables is $2.9 million (2023), against an average of $3.4 million.
  • Year-over-year, Payables skyrocketed 574.25% in 2023 and then tumbled 74.9% in 2025.
  • A 5-year view of Payables shows it stood at $896828.0 in 2021, then surged by 135.46% to $2.1 million in 2022, then surged by 141.24% to $5.1 million in 2023, then dropped by 21.61% to $4.0 million in 2024, then plummeted by 36.39% to $2.5 million in 2025.
  • Per Business Quant, the three most recent readings for IVF's Payables are $2.5 million (Q3 2025), $5.1 million (Q2 2025), and $11.3 million (Q1 2025).